A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients

Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial

(2015) Marcelo E. Bigal et al.   HEADACHE

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

(2015) Richard B. Lipton et al.   HEADACHE

Psychosocial Adjustment of Children With Migraine and Tension-Type Headache - A Nationwide Study

(2015) Marco A. Arruda et al.   HEADACHE

Sumatriptan Transdermal System Can Be Correctly Assembled and Applied During Migraine Attacks

(2014) Kappa P. Meadows et al.   HEADACHE

Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results

(2014) Michael L. Reed et al.   HEADACHE

Behavioral and emotional symptoms and primary headaches in children: A population-based study

(2012) Marco A Arruda et al.   CEPHALALGIA

Frequency and Burden of Headache-Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study

(2012) Richard B. Lipton et al.   HEADACHE

Twelve-Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System

(2012) Timothy R. Smith et al.   HEADACHE

Migraine and migraine subtypes in preadolescent children: Association with school performance

(2012) M. A. Arruda et al.   NEUROLOGY

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

(2012) Michail Vikelis et al.   Neuropsychiatric Disease and Treatment

Migraine in the Pediatric Population-Evolving Concepts

(2010) Marcelo E. Bigal et al.   HEADACHE